Protocol #CTH-301: An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients with Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes) .”

  • Zadikoff, Cindy (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date11/19/1511/19/21

Funding

  • INC Research, LLC (Protocol #CTH-301)
  • Cynapsus Therapeutics Inc. (Protocol #CTH-301)